Procarbazine and Lomustine in Recurrent Glioblastoma

Clinical trial NCT01737346 · UNKNOWN

Trial details

NCT number: NCT01737346
Sponsor: Incheon St.Mary's Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma Multiforme

Start date: 2012-10-01
Primary completion: 2013-09-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.